Partnering with X4 Pharmaceuticals, Inc. in its First FDA Approval in Rare Disease
Branding and series A launch for a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Rebrand to usher in the next phase of the C4 Therapeutics story.
A Landmark for Genome Editing
A clinical-stage debut for a precision player in the neuro space
New company name and brand identity support a vision fueled by optimism
Igniting global recognition of a landmark approval
